Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Radiopharmaceuticals in Nuclear Medicine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Radiopharmaceuticals in Nuclear Medicine are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Radiopharmaceuticals in Nuclear Medicine market segmented into
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Based on the end-use, the global Radiopharmaceuticals in Nuclear Medicine market classified into
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Others
Based on geography, the global Radiopharmaceuticals in Nuclear Medicine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE INDUSTRY
2.1 Summary about Radiopharmaceuticals in Nuclear Medicine Industry
2.2 Radiopharmaceuticals in Nuclear Medicine Market Trends
2.2.1 Radiopharmaceuticals in Nuclear Medicine Production & Consumption Trends
2.2.2 Radiopharmaceuticals in Nuclear Medicine Demand Structure Trends
2.3 Radiopharmaceuticals in Nuclear Medicine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Diagnostic Radiopharmaceuticals
4.2.2 Therapy Radiopharmaceuticals
4.2.3 Enriched Stable Isotopes
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Diagnostic Application
4.3.2 Therapeutic Application
4.3.3 Research
4.3.4 Pharmaceutical
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Diagnostic Radiopharmaceuticals
5.2.2 Therapy Radiopharmaceuticals
5.2.3 Enriched Stable Isotopes
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Diagnostic Application
5.3.2 Therapeutic Application
5.3.3 Research
5.3.4 Pharmaceutical
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Diagnostic Radiopharmaceuticals
6.2.2 Therapy Radiopharmaceuticals
6.2.3 Enriched Stable Isotopes
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Diagnostic Application
6.3.2 Therapeutic Application
6.3.3 Research
6.3.4 Pharmaceutical
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Diagnostic Radiopharmaceuticals
7.2.2 Therapy Radiopharmaceuticals
7.2.3 Enriched Stable Isotopes
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Diagnostic Application
7.3.2 Therapeutic Application
7.3.3 Research
7.3.4 Pharmaceutical
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Diagnostic Radiopharmaceuticals
8.2.2 Therapy Radiopharmaceuticals
8.2.3 Enriched Stable Isotopes
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Diagnostic Application
8.3.2 Therapeutic Application
8.3.3 Research
8.3.4 Pharmaceutical
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Diagnostic Radiopharmaceuticals
9.2.2 Therapy Radiopharmaceuticals
9.2.3 Enriched Stable Isotopes
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Diagnostic Application
9.3.2 Therapeutic Application
9.3.3 Research
9.3.4 Pharmaceutical
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bracco Imaging S.P.A.
10.1.2 Cambridge Isotope Laboratories, Inc.
10.1.3 Cardinal Health, Inc.
10.1.4 Covidien, Plc
10.1.5 Eczacibasi-Monrol
10.1.6 Fujifilm Holdings Corporation
10.1.7 GE Healthcare (Subsidiary Of General Electric Company)
10.1.8 IBA Group
10.1.9 Isotec, Inc. (Sigma-Aldrich)
10.1.10 Lantheus Medical Imaging, Inc.
10.1.11 Nordion, Inc.
10.1.12 Ntp Radioisotopes (Pty), Ltd.
10.1.13 Siemens Healthcare (Subsidiary Of Siemens AG)
10.1.14 Taiyo Nippon Sanso Corporation
10.1.15 Urenco Limited
10.1.16 Rotem Industries, Ltd., Inc.
10.1.17 Australian Nuclear Association And Technology Organization (ANSTO)
10.1.18 Board of Radiation And Isotope Technology (BRIT)
10.1.19 Institute of Atomic Energy Polatom Radioisotope Centre
10.1.20 Institute of Isotopes Co., Ltd.
10.1.21 Institute Of Radioelement (IRE)
10.2 Radiopharmaceuticals in Nuclear Medicine Sales Date of Major Players (2017-2020e)
10.2.1 Bracco Imaging S.P.A.
10.2.2 Cambridge Isotope Laboratories, Inc.
10.2.3 Cardinal Health, Inc.
10.2.4 Covidien, Plc
10.2.5 Eczacibasi-Monrol
10.2.6 Fujifilm Holdings Corporation
10.2.7 GE Healthcare (Subsidiary Of General Electric Company)
10.2.8 IBA Group
10.2.9 Isotec, Inc. (Sigma-Aldrich)
10.2.10 Lantheus Medical Imaging, Inc.
10.2.11 Nordion, Inc.
10.2.12 Ntp Radioisotopes (Pty), Ltd.
10.2.13 Siemens Healthcare (Subsidiary Of Siemens AG)
10.2.14 Taiyo Nippon Sanso Corporation
10.2.15 Urenco Limited
10.2.16 Rotem Industries, Ltd., Inc.
10.2.17 Australian Nuclear Association And Technology Organization (ANSTO)
10.2.18 Board of Radiation And Isotope Technology (BRIT)
10.2.19 Institute of Atomic Energy Polatom Radioisotope Centre
10.2.20 Institute of Isotopes Co., Ltd.
10.2.21 Institute Of Radioelement (IRE)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
Table Radiopharmaceuticals in Nuclear Medicine Product Type Overview
Table Radiopharmaceuticals in Nuclear Medicine Product Type Market Share List
Table Radiopharmaceuticals in Nuclear Medicine Product Type of Major Players
Table Brief Introduction of Bracco Imaging S.P.A.
Table Brief Introduction of Cambridge Isotope Laboratories, Inc.
Table Brief Introduction of Cardinal Health, Inc.
Table Brief Introduction of Covidien, Plc
Table Brief Introduction of Eczacibasi-Monrol
Table Brief Introduction of Fujifilm Holdings Corporation
Table Brief Introduction of GE Healthcare (Subsidiary Of General Electric Company)
Table Brief Introduction of IBA Group
Table Brief Introduction of Isotec, Inc. (Sigma-Aldrich)
Table Brief Introduction of Lantheus Medical Imaging, Inc.
Table Brief Introduction of Nordion, Inc.
Table Brief Introduction of Ntp Radioisotopes (Pty), Ltd.
Table Brief Introduction of Siemens Healthcare (Subsidiary Of Siemens AG)
Table Brief Introduction of Taiyo Nippon Sanso Corporation
Table Brief Introduction of Urenco Limited
Table Brief Introduction of Rotem Industries, Ltd., Inc.
Table Brief Introduction of Australian Nuclear Association And Technology Organization (ANSTO)
Table Brief Introduction of Board of Radiation And Isotope Technology (BRIT)
Table Brief Introduction of Institute of Atomic Energy Polatom Radioisotope Centre
Table Brief Introduction of Institute of Isotopes Co., Ltd.
Table Brief Introduction of Institute Of Radioelement (IRE)
Table Products & Services of Bracco Imaging S.P.A.
Table Products & Services of Cambridge Isotope Laboratories, Inc.
Table Products & Services of Cardinal Health, Inc.
Table Products & Services of Covidien, Plc
Table Products & Services of Eczacibasi-Monrol
Table Products & Services of Fujifilm Holdings Corporation
Table Products & Services of GE Healthcare (Subsidiary Of General Electric Company)
Table Products & Services of IBA Group
Table Products & Services of Isotec, Inc. (Sigma-Aldrich)
Table Products & Services of Lantheus Medical Imaging, Inc.
Table Products & Services of Nordion, Inc.
Table Products & Services of Ntp Radioisotopes (Pty), Ltd.
Table Products & Services of Siemens Healthcare (Subsidiary Of Siemens AG)
Table Products & Services of Taiyo Nippon Sanso Corporation
Table Products & Services of Urenco Limited
Table Products & Services of Rotem Industries, Ltd., Inc.
Table Products & Services of Australian Nuclear Association And Technology Organization (ANSTO)
Table Products & Services of Board of Radiation And Isotope Technology (BRIT)
Table Products & Services of Institute of Atomic Energy Polatom Radioisotope Centre
Table Products & Services of Institute of Isotopes Co., Ltd.
Table Products & Services of Institute Of Radioelement (IRE)
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (Million USD) by Region 2021f-2026f
Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapy Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enriched Stable Isotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmaceutical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapy Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enriched Stable Isotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmaceutical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapy Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enriched Stable Isotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmaceutical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapy Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enriched Stable Isotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmaceutical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapy Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enriched Stable Isotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmaceutical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapy Radiopharmaceuticals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enriched Stable Isotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmaceutical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Bracco Imaging S.P.A. 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Cambridge Isotope Laboratories, Inc. 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Cardinal Health, Inc. 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Covidien, Plc 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Eczacibasi-Monrol 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Fujifilm Holdings Corporation 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of GE Healthcare (Subsidiary Of General Electric Company) 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of IBA Group 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Isotec, Inc. (Sigma-Aldrich) 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Lantheus Medical Imaging, Inc. 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Nordion, Inc. 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Ntp Radioisotopes (Pty), Ltd. 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Siemens Healthcare (Subsidiary Of Siemens AG) 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Taiyo Nippon Sanso Corporation 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Urenco Limited 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Rotem Industries, Ltd., Inc. 2017-2020e
Figure Radiopharmaceuticals in Nuclear Medicine Sales Revenue (Million USD) of Australian Nuclear Association And Technology Organization (ANSTO) 2017-2020e
Figure Sales Revenue (Million USD) of Board of Radiation And Isotope Technology (BRIT) 2017-2020e
Figure Sales Revenue (Million USD) of Institute of Atomic Energy Polatom Radioisotope Centre 2017-2020e
Figure Sales Revenue (Million USD) of Institute of Isotopes Co., Ltd. 2017-2020e
Figure Sales Revenue (Million USD) of Institute Of Radioelement (IRE) 2017-2020e
Request Sample 
Request Discount 
Inquire Before Buy
